HSA Adverse Drug Reaction News 2023 May, Vol.25 No.1

HSA Adverse Drug Reaction News 2023 May, Vol.25 No.1

The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.

• ADR_News_May2023_Vol25_No1 [PDF, 2.6 MB]

This issue includes the following topics:

• Analysis of adverse event reports with COVID-19 therapeutics for the treatment or prophylaxis of COVID-19

• Analysis of adverse event (AE) reports for health products for year 2022 

• Analysis of COVID-19 vaccine adverse event reports for year 2022 

• High-dose vitamin B6 and risk of peripheral neuropathy 

• Navigation made easy – explore HSA’s website for adverse event reporting and safety information related to health products.